Results
20
Companies with a Future performance score of at least 3, ordered by Future performance score.
20 companies
PharmaResearch
Market Cap: ₩4.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩436,000.00
7D
-0.8%
1Y
223.9%
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩28,800.00
7D
6.5%
1Y
-5.0%
ALTEOGEN
Market Cap: ₩17.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩333,500.00
7D
2.3%
1Y
83.1%
ABL Bio
Market Cap: ₩3.9t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩79,700.00
7D
21.5%
1Y
245.0%
Hugel
Market Cap: ₩3.3t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩324,500.00
7D
-11.3%
1Y
55.6%
Caregen
Market Cap: ₩1.6t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩32,300.00
7D
-4.9%
1Y
52.7%
LigaChem Biosciences
Market Cap: ₩4.2t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩114,800.00
7D
5.0%
1Y
85.5%
Hanall Biopharma
Market Cap: ₩1.3t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩25,250.00
7D
-2.5%
1Y
-31.1%
Seegene
Market Cap: ₩1.4t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩31,400.00
7D
-0.9%
1Y
48.8%
SK Biopharmaceuticals
Market Cap: ₩7.1t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩90,300.00
7D
-2.4%
1Y
9.3%
Dong-A Socio Holdings
Market Cap: ₩695.1b
Engages in the pharmaceutical business in South Korea.
A000640
₩108,000.00
7D
6.2%
1Y
9.5%
Celltrion
Market Cap: ₩33.3t
Develops and produces drugs based on proteins for the treatment of oncology in South Korea.
A068270
₩156,000.00
7D
-0.4%
1Y
-8.4%
ST PharmLtd
Market Cap: ₩1.5t
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
A237690
₩76,400.00
7D
0.9%
1Y
-14.6%
Humedix
Market Cap: ₩539.7b
Engages in the manufacture and sale of various pharmaceutical products in South Korea.
A200670
₩52,300.00
7D
2.1%
1Y
56.1%
GC Biopharma
Market Cap: ₩1.4t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩124,800.00
7D
-0.2%
1Y
11.5%
Yuhan
Market Cap: ₩7.8t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩104,500.00
7D
-3.7%
1Y
49.9%
Macrogen
Market Cap: ₩168.3b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩15,520.00
7D
0.8%
1Y
-23.2%
Medy-Tox
Market Cap: ₩1.1t
Operates as a biopharmaceutical company in South Korea.
A086900
₩168,200.00
7D
-2.0%
1Y
25.6%
Dong-A ST
Market Cap: ₩431.1b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩47,050.00
7D
-2.5%
1Y
-22.1%
Daewoong Pharmaceutical
Market Cap: ₩1.6t
Manufactures and sells pharmaceutical products in South Korea and internationally.
A069620
₩140,100.00
7D
-3.5%
1Y
31.5%